NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines
Clinical trial NCT00777803 · COMPLETED
Trial details
- NCT number
- NCT00777803
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2009-04-01
- Enrollment
- 381
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.